omniture
上海药明生物技术有限公司 Wuxi Biologics

Latest News

WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection

SUZHOU, China, April 13, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global compa...

2020-04-14 08:00 6810

WuXi Biologics Achieved Remarkable Results in 2019

57.2% Revenue Growth to RMB3,983.7 Million 63.0% Gross Profit Growth to RMB1,658.8 Million Adjuste...

2020-03-26 21:32 5704

WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland

DUNDALK, Ireland, March 11, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g...

2020-03-11 08:00 1833

WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19

SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-02-25 21:30 2223

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2020-02-24 08:00 5597

WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global op...

2020-02-18 18:42 2053

WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Vaccines, a new vaccine Contract Development and Manuf...

2020-02-18 18:18 3470

WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak

SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- WuXi Biologics is closely monitoring the coronavirus outbre...

2020-02-12 08:00 6590

WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak

SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- The coronavirus outbreak is having a potentially significan...

2020-01-29 10:44 2240

WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2020-01-29 10:00 2913

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany

* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufac...

2020-01-16 10:39 17764

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing ...

2020-01-09 17:10 2212

WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2020-01-02 08:08 2164

WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2019-12-23 16:26 1883

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading gl...

2019-11-23 01:55 4264

WuXi Biologics Reports Outstanding Interim Results

* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Y...

2019-08-19 22:09 10799

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WUXI, China, June 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ...

2019-06-21 08:39 3510

WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract

SHANGHAI, May 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open...

2019-05-21 07:30 3473

WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu

CHENGDU, China, May 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading globa...

2019-05-16 15:39 3753

WuXi Biologics Successfully Completed First FDA Routine GMP Inspection

SHANGHAI, April 17, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global op...

2019-04-17 09:14 3310